Bend Research's high containment spray dryer.
in the company's expertise. The initial interest was around
the company's membrane technology for controlled release,
but later the focus was more on inventing and applying new
This goal led to Bend Research building their first GMP
facility with the intention of using it to take projects from
the concept stage, through pilot plant to clinical trials, and
finally to commercial manufacturing.
Around 1995, the decision was made that Bend Research was
to start doing work exclusively for Pfizer. This began approximately 10 years of rapid growth, positioning the company as a
Unless you are making cookies, the term “cook- ie-cutter” has certain negative connotations associated with it. For example, if you are looking for someone to help you solve a problem, you
most definitely do not want them to adopt a “cookie-cutter”
approach; you want them to look at your problem, suggest
solutions, work with you in a collaborative manner, become
part of your team, and solve the problem.
In the world of solid dosage formulation, development
and manufacturing services one company stands out as a
true problem solver: Capsugel, through the formation of its
Dosage Form Solutions business unit and subsequent acquisitions of Encap Drug Delivery and Bend Research, has
emerged as the industry's go-to source for solving key formulation challenges, including bioavailability enhancement,
targeted and modified release, to help companies develop
specialized applications for their developing compounds.
BACKGROUND AND HISTORY
The story of how Capsugel and Bend Research came to-
gether is an interesting one, and one that
illustrates how two companies with sim-
ilar values, and similar aspirations can
come together and form something that is
greater than the sum of its parts.
Capsugel, a global leader in capsule design, portfolio, and manufacturing, has a
history dating back more than 100 years.
Bend Research’s roots date back to 1975
when two membrane chemists wanted to
do contract research work and live in the
best place they could find. They settled
in Bend, Oregon, and although they were
doing research, they laid a foundation
for the company, in that they didn’t want
to do research for research’s sake – they
wanted their research to culminate in a
product. It was this philosophy that eventually led the growing company to adapt
its membrane technologies to pharmaceutical tablet applications.
In the mid-80's Pfizer took an interest
■ By Mike Auerbach, Editor in Chief
Capsugel acquires Bend Research and Encap Drug Delivery to create a
comprehensive solid dosage form solutions group